Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay

ConclusionsIn BC patients who had received NAST and underwent SLNB analysis using OSNA, a TTL value of > 25,000 copies/μL was associated with a higher progression risk and > 15,000 copies/μL was predictive of non-SLN involvement.

http://rd.springer.com/10.1007/s12094-023-03347-7

Source: Clinical and Translational Oncology - December 9, 2023 Category: Cancer & Oncology Source Type: research